Metraipolis › archive › dc_cec0cd421534

Engineered AcrIIA5 for optogenetic control of CRISPR-Cas9-based genome editing — Europe PMC PMID:41479407

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41479407
DOI
10.1002/mlf2.70016
License (as archived)
solo-consultazione
Archived
2026-11-07T16:41:34.726Z
SHA-256 of the archived text
f311378213ea36d9e35558b578c83d941711a559306ef7a175a7a6ae7dafdab8
Stable URL of this page
https://metraipolis.com/documento/dc_cec0cd421534

How to cite

Engineered AcrIIA5 for optogenetic control of CRISPR-Cas9-based genome editing — Europe PMC PMID:41479407 — Europe PMC (en), https://europepmc.org/article/MED/41479407 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cec0cd421534 (Metraipolis archive dc_cec0cd421534, sha256 f311378213ea36d9e35558b578c83d941711a559306ef7a175a7a6ae7dafdab8)
BibTeX
@misc{dccec0cd421534,
  title = {Engineered AcrIIA5 for optogenetic control of CRISPR-Cas9-based genome editing — Europe PMC PMID:41479407},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41479407},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cec0cd421534; sha256 f311378213ea36d9e35558b578c83d941711a559306ef7a175a7a6ae7dafdab8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41479407. Agents can read the archived copy with the MCP tool read_document.